Rick Martin

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

Joseph Muenzer, J. E. Wraith, Michael Beck et al. · Genetics in Medicine · 2006 · 585 citations · Full text

Life Sciences, Biochemistry, Enzymology +10

Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome

Joseph Muenzer, Michael Beck, Christine M. Eng et al. · Genetics in Medicine · 2010 · 232 citations · Full text

Life Sciences, Biochemistry, Enzymology +1

Initial report from the Hunter Outcome Survey

J. E. Wraith, Michael Beck, Roberto Giugliani et al. · Genetics in Medicine · 2008 · 190 citations

Life Sciences, Internal Medicine, Pathology +15

Trismus‐pseudocamptodactyly syndrome is caused by recurrent mutation of <i>MYH8</i>

Reha M. Toydemir, Harold Chen, Virginia K. Proud et al. · American Journal of Medical Genetics Part A · 2006 · 74 citations

Life Sciences, Genetics, Molecular Genetics +8

Agalsidase alfa in pediatric patients with Fabry disease: a 6.5-year open-label follow-up study

Raphael Schiffmann, Gregory M. Pastores, Yeong‐Hau H. Lien et al. · Orphanet Journal of Rare Diseases · 2014 · 37 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +12